Rakovina Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Finance
  • ISIN: CA75103L1013
CAD
0.12
-0.01 (-7.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Rakovina Therapeutics, Inc. stock-summary
stock-summary
Rakovina Therapeutics, Inc.
Finance
Vincero Capital Corp. is a Canada-based capital pool company. The Company’s principal business is the identification and evaluation of assets or businesses, with a view to completing a qualifying transaction. The Company has no commercial operations and has no assets.
Company Coordinates stock-summary
Company Details
2201 - 8 Smithe Mews , Vancouver BC : V6B 0A5
stock-summary
Tel: 1 604 6190225
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-3 Million
stock-summary
Industry

Finance

stock-summary
Market cap

CAD 6 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-230.25%

stock-summary
Price to Book

1.74